Download: The use of Mass Spectrometry for the characterization of originator and biosimilar mAbs

Download this presentation here > The World Biosimilar Congress  brings together pharma, biotech, academia and regulators and the wider service provider community to discuss the latest R&D, process, production, regulation and to-market strategies for biosimilar medicines. At the 2013 event, delegates were fortunate enough to hear from Dr Alain Beck, Senior Director, Antibody  Physico-Chemistry, Centre d’Immunologie Pierre Fabre; Associate Editor, mAbs, Landes Bioscience, who delivered the presentation ‘The use of …